TAMBE Japan Post-Marketing Surveillance
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorW.L.Gore & Associates
About this trial
To evaluate the safety and efficacy of multi component system (TAMBE device) including GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (Aortic Component; AC) under post-marketing use.
Eligibility criteria
Qualifiers
Patients who were attempted to implant the AC
Thoracoabdominal aortic aneurysm
Pararenal abdominal aortic aneurysm
Disqualifiers
N/A
Trial design
Treatments tested in this trial
- GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis
Treatment groups
100 Participants
are divided into 1 treatment groupLocations
5The Jikei University Hospital Minatoku Japan
Nagoya University Hospital Nagoya Japan
Morinomiya Hospital Osaka Japan
Osaka International Medical & Science Center Osaka Police Hospital Osaka Japan
Sponsors and collaborators
W.L.Gore & Associates
Lead sponsor
CMIC Co, Ltd. Japan
Collaborator
Source ClinicalTrials.gov